Literature DB >> 18754810

Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation.

Matthew Thomas1, Matthew J Edwards, Elzbieta Sawicka, Nicholas Duggan, Emilio Hirsch, Matthias P Wymann, Charles Owen, Alexandre Trifilieff, Christoph Walker, John Westwick, Peter Finan.   

Abstract

We and others have established an important role for phosphoinositide-3 kinase gamma (PI3Kgamma) in the chemotactic responses of macrophages and neutrophils. The involvement of this lipid kinase in allergic inflammatory responses is, however, yet to be fully determined. Here we compare wild-type (WT) and PI3Kgamma(-/-) (KO) mice within a model of ovalbumin (OVA) -specific pulmonary inflammation. Upon OVA aerosol challenge, cell influx into the bronchoalveolar lavage (BAL) fluid consisted of neutrophils, macrophages and, more significantly, eosinophils - which are key effector cells in allergic inflammation. Each population was reduced by up to 80% in KO mice, demonstrating a role for PI3Kgamma in cell infiltration into the airways. The mechanism of reduced eosinophilia was analysed within both development and effector stages of the immune response. Comparable levels of OVA-specific T-cell proliferation and immunoglobulin production were established in both strains. Furthermore, no significant differences between WT and KO chemokine production were observed. Having identified the critical point of PI3Kgamma involvement, KO eosinophil chemotactic dysfunction was confirmed in vitro. These data are the first to demonstrate the vital role of PI3Kgamma in acute allergic inflammation. The profound dependency of eosinophils on PI3Kgamma for pulmonary influx identifies this lipid kinase as an attractive target for the pharmacological intervention of asthma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754810      PMCID: PMC2669822          DOI: 10.1111/j.1365-2567.2008.02908.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  68 in total

1.  The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.

Authors:  L R Stephens; A Eguinoa; H Erdjument-Bromage; M Lui; F Cooke; J Coadwell; A S Smrcka; M Thelen; K Cadwallader; P Tempst; P T Hawkins
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

2.  Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.

Authors:  Kyung Sun Lee; Seoung Ju Park; So Ri Kim; Kyung Hoon Min; Sun Mi Jin; Kamal D Puri; Yong Chul Lee
Journal:  J Allergy Clin Immunol       Date:  2006-06-06       Impact factor: 10.793

Review 3.  Cytokine generation by eosinophils.

Authors:  R Moqbel; F Levi-Schaffer; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

4.  Identification of interleukin-2 in human peripheral blood eosinophils.

Authors:  F Levi-Schaffer; J Barkans; T M Newman; S Ying; M Wakelin; R Hohenstein; V Barak; P Lacy; A B Kay; R Moqbel
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

5.  Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation.

Authors:  Baher F Nashed; Tingting Zhang; Monther Al-Alwan; Ganesh Srinivasan; Andrew J Halayko; Klaus Okkenhaug; Bart Vanhaesebroeck; Kent T Hayglass; Aaron J Marshall
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

Review 6.  Targeting phosphoinositide 3-kinase: moving towards therapy.

Authors:  Romina Marone; Vladimir Cmiljanovic; Bernd Giese; Matthias P Wymann
Journal:  Biochim Biophys Acta       Date:  2007-10-12

7.  Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils.

Authors:  H Nakajima; G J Gleich; H Kita
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.

Authors:  E A Garcia-Zepeda; M E Rothenberg; R T Ownbey; J Celestin; P Leder; A D Luster
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  PI3K is a negative regulator of IgE production.

Authors:  Tomomitsu Doi; Kunie Obayashi; Takashi Kadowaki; Hideki Fujii; Shigeo Koyasu
Journal:  Int Immunol       Date:  2008-02-25       Impact factor: 4.823

10.  Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.

Authors:  B Stoyanov; S Volinia; T Hanck; I Rubio; M Loubtchenkov; D Malek; S Stoyanova; B Vanhaesebroeck; R Dhand; B Nürnberg
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  11 in total

Review 1.  Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis.

Authors:  Enrico Lupia; Luca Pigozzi; Alberto Goffi; Emilio Hirsch; Giuseppe Montrucchio
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

2.  Class I PI3K Biology.

Authors:  Tihitina Y Aytenfisu; Hannah M Campbell; Mayukh Chakrabarti; L Mario Amzel; Sandra B Gabelli
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

3.  Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors.

Authors:  Zied Gaieb; Kaelin D Fleming; Manoj K Rathinaswamy; Chiara Borsari; Noah J Harris; Brandon E Moeller; Matthias P Wymann; Rommie E Amaro; John E Burke
Journal:  Elife       Date:  2021-03-04       Impact factor: 8.140

4.  PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.

Authors:  Iain Comerford; Wendel Litchfield; Ervin Kara; Shaun R McColl
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway.

Authors:  Chang Cheng; W Eugene Ho; Fera Y Goh; Shou Ping Guan; Li Ren Kong; Wen-Qi Lai; Bernard P Leung; W S Fred Wong
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

6.  IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.

Authors:  Nicola M Heller; William M Gwinn; Raymond P Donnelly; Stephanie L Constant; Achsah D Keegan
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

Review 7.  Advanced Role of Neutrophils in Common Respiratory Diseases.

Authors:  Jinping Liu; Zhiqiang Pang; Guoqiang Wang; Xuewa Guan; Keyong Fang; Ziyan Wang; Fang Wang
Journal:  J Immunol Res       Date:  2017-05-15       Impact factor: 4.818

8.  Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology.

Authors:  Andrew J Takeda; Timothy J Maher; Yu Zhang; Stephen M Lanahan; Molly L Bucklin; Susan R Compton; Paul M Tyler; William A Comrie; Makoto Matsuda; Kenneth N Olivier; Stefania Pittaluga; Joshua J McElwee; Debra A Long Priel; Douglas B Kuhns; Roger L Williams; Peter J Mustillo; Matthias P Wymann; V Koneti Rao; Carrie L Lucas
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

9.  Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo.

Authors:  Xuezhen Xu; Ok-Kyoung Kwon; In-Sik Shin; Jyotirling R Mali; Dipesh S Harmalkar; Yourim Lim; Gilhye Lee; Qili Lu; Sei-Ryang Oh; Kyung-Seop Ahn; Hye-Gwang Jeong; Kyeong Lee
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

Review 10.  For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.

Authors:  Christina M Buchanan; Kate L Lee; Peter R Shepherd
Journal:  Biomolecules       Date:  2019-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.